AlphaRx To Present April 5 At Dutton Associates Conference In San Francisco.

EL DORADO HILLS, Calif. -- AlphaRx (OTCBB:ALRX) announced that Michael Lee, CEO, is scheduled to present at the Dutton Associates Small-Cap Conference at the Four Seasons Hotel located in downtown San Francisco, California on Tuesday, April 5, 2005. AlphaRx is scheduled to present three times, at 8:30, 2:00 and 3:30 PST at the conference. The morning presentation will be broadcast, with a link for use either at www.jmdutton.com or on the company's website. E[acute accent]Dutton Associates' 2005 Small-Cap Conference, "Recognizing Opportunity," will offer a unique opportunity for investment professionals to meet with top companies covered by Dutton Associates and the firm's research analysts. The one-day conference will feature morning presentations by senior executives of 18 public companies and afternoon breakout sessions with the individual companies. Michael Mayhew of Integrity Research Associates will deliver the luncheon keynote address, "The Future of Wall Street Research." Conference attendees may also learn more at the Industry Sectors Panel discussion, scheduled immediately after lunch. E[acute accent]Professional investors wishing to attend the conference should go to the registration link at www.jmdutton.com. E[acute accent]AlphaRx is a drug delivery company specializing in the development of innovative therapeutic products for the pharmaceutical and consumer health care market. The Company's primary focus is the development of drug formulations for therapeutic molecules or compounds that have exhibited poor G.I. absorption due to poor solubility or are not yet able to be administered to the body with an acceptable delivery method. The Company is focusing on the clinical development of Indaflex, a topical NSAID formulation intended for use in the treatment of symptoms of arthritis. The Company has entered into a licensing agreement with Industria Farmaceutica Andromuco for the sale and distribution of Indaflex in Mexico.